Alpha Healthcare Acquisition Corp. AHAC
10.96 +10.96
Day range unavailable
52-week range unavailable
News
globenewswire.com Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp. DURHAM, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,…
benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday morning, 173 companies reached new 52-week lows.
globenewswire.com Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination NEW YORK and DURHAM, N.C., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, today announced that it has filed a…
benzinga.com EXCLUSIVE: Humacyte, Alpha Healthcare CEOs Talk SPAC Deal, Technology, Trials On 'SPACs Attack' Humacyte is set to go public via the special purpose acquisition company Alpha Healthcare Acquisition Corp (NASDAQ: AHAC) in a deal that values the company at around $800 million. Humacyte founder…
fool.com 2 SPAC Stocks That Could Be 10-Baggers They could even deliver greater gains than just a 10-times return.
globenewswire.com Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021 DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,…
seekingalpha.com Humacyte: Disrupting The Organ Transplant Industry Humacyte has a platform technology allowing for the mass production of human organs and blood vessels within a laboratory. Its products are superior as they can be stored for over a year, pose little…
benzinga.com 40 Stocks Moving in Thursday's Pre-Market Session Gainers AmeriServ Financial, Inc. (NASDAQ: ASRV) rose 199.3% to $12.30 in pre-market trading.
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning trading, 285 companies set new 52-week highs.
fool.com Regenerative Tissue Developer Humacyte Going Public Via SPAC Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 194 companies reached new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Friday During the morning session on Friday, 389 stocks hit new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Thursday During Thursday's morning session, 255 companies made new 52-week highs.